EUVIMED · CrossrefJournal
Blood and Lymphatic Cancer: Targets and Therapy
ISSN 1179-9889 · Informa UK Limited
Latest articles
Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study
Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia
Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study
A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation
Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients
Enzymatic Laccase Nanoreactors Induce Apoptosis in MOLT-4-ALL Cells and Activate Prodrugs in a Synergetic Effect
Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review
Poor Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia Harboring Low P16 Deletion Ratio: A Post-Hoc Analysis from a Prospective Cohort
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study
Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2
Prognostic Value of the Aggregate Inflammation Systemic Index (AISI) in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter Retrospective Study
Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy
Construction and Validation of an N7-Methylguanosine–Related Prognostic Model for Acute Myeloid Leukemia
An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma
Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review
Human Immunodeficiency Virus Related Non-Hodgkin’s Lymphoma
HIV/AIDS Associated Lymphoma: Review
Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma
Impact of obinutuzumab alone and in combination for follicular lymphoma
Complications and management of coagulation disorders in leukemia patients
Current understanding of the role and regulation of miRNAs in Burkitt lymphoma
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
Uptake of lymphoma-derived exosomes by peripheral blood leukocytes
Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects
Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
Plasmablastic lymphoma: current perspectives
Advances in the diagnosis and management of lymphoma
EUVIMED